TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

10641	Companies
226254	Keywords
154734	Articles
119736	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 06/03/2024 at 07:30, 2 years ago

Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou
Transgene annonce l'inclusion du premier patient dans la partie Phase II de l'étude randomisée de Phase I/II pour son vaccin TG4050 dans les cancers de la tête et du cou. Démarrage de la sélection des patients pour cette étude internationale

Cancer De La Tête Et Du Cou Étude Clinique Transgene Vaccin Thérapeutique Néoantigènes
PRESS RELEASE

published on 06/03/2024 at 07:30, 2 years ago

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025

Phase II Trial Head And Neck Cancer Cancer Vaccine Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 2 years 1 month ago

Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 2 years 1 month ago

Transgene annonce une mise à jour positive pour le premier trimestre 2024 et de futures étapes cliniques

Essais Cliniques Mise À Jour Financière Immunothérapie Anticancéreuse Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 2 years 1 month ago

Transgene provides business and financial update for Q1 2024
Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024

Clinical Data Q1 2024 Financial Update Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 2 years 1 month ago

Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024
Point sur les activités et la situation financière de Transgene au premier trimestre 2024, avec des données prometteuses de Phase I pour TG4050 et des prévisions de nouvelles données cliniques pour TG4001, TG6050 et BT-001

Biotechnologie Santé Financière Immunothérapie Transgene TG4050

Accesswire

Published on 06/25/2026 at 15:30, 2 hours 27 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/25/2026 at 15:00, 2 hours 57 minutes ago

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Published on 06/25/2026 at 14:30, 3 hours 27 minutes ago

Unusual Machines Expands Orlando Manufacturing Footprint to Support Battery Operations
Published on 06/25/2026 at 14:01, 3 hours 56 minutes ago

Worksport (NASDAQ:WKSP) Regains $1 Bid Price Requirement, Announces CEO Town Hall, Highlights Multiple Recent Growth Drivers in CEO Letter
Published on 06/25/2026 at 14:00, 3 hours 57 minutes ago

Horizon Aircraft's Leadership Team to Participate at Farnborough International Airshow 2026

View all ACCESSWIRE

EQS Group

Published on 06/25/2026 at 17:45, 12 minutes ago

REALITE annonce un nouveau report de la publication de ses résultats annuels 2025 et ajuste en conséquence le calendrier de ses opérations de conversion de créances en capital
Published on 06/25/2026 at 17:30, 27 minutes ago

TFREE Formally Launches at EUROBIKE 2026: Architecting the Operating System for AI Micro Mobility
Published on 06/25/2026 at 17:08, 49 minutes ago

Grand City Properties S.A. announces dividend of EUR 0.30 per share
Published on 06/25/2026 at 17:07, 50 minutes ago

Grand City Properties S.A. announces dividend of EUR 0.30 per share
Published on 06/25/2026 at 17:06, 51 minutes ago

Aroundtown SA announces dividend of EUR 0.08 per share

Les Echos

Published on 06/25/2026 at 17:50, 7 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 06/25/2026 at 17:50, 7 minutes ago

DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 06/25/2026 at 15:58, 1 hour 59 minutes ago

260625 BENETEAU Transactions sur actions propres
Published on 06/25/2026 at 07:30, 10 hours 27 minutes ago

Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
Published on 06/25/2026 at 07:30, 10 hours 27 minutes ago

Gimv ondertekent een overeenkomst voor de overname van Groupe Cap Vert, de Franse marktleider in multispecialistische essentiële diensten voor het beheer van bomen en groene infrastructuur, van Ambienta.

View all LES ECHOS COMFI WIRE